Decreased myometrial p160 ROCK-1 expression in obese women at term pregnancy  by unknown
O’Brien et al. Reproductive Biology and Endocrinology 2013, 11:79
http://www.rbej.com/content/11/1/79RESEARCH Open AccessDecreased myometrial p160 ROCK-1 expression
in obese women at term pregnancy
Margaret O’Brien1*, Shawna Carbin2, John J Morrison1 and Terry J Smith2Abstract
Background: Obesity is becoming an increasing problem in obstetric practice; it has led to an increase in the risk of
caesarean delivery, prolonged pregnancy and dysfunctional labour. It has been postulated that many of these problems
are as a result of abnormal myometrial contractility. The RhoA/Rho kinase pathway is involved in calcium sensitisation in
the myometrium during labour and contributes to the phosphorylation of myosin phosphatase and thus continued
myosin light chain activity, during uterine contractility. The aim of this study therefore, was to investigate the effect of
obesity on the expression of various components of the RhoA/ROCK pathway in human myometrium at term pregnancy.
Methods: Protein was isolated from myometrial biopsies obtained at elective caesarean section, at term pregnancy
from obese women and from those with a normal body mass index. Western blotting was performed using specific
primary antibodies to RhoA/ Rho kinase associated proteins.
Results: The protein expression of p160 ROCK-1 was significantly decreased (P < 0.001) in the myometrium from
women in the obese cohort (n = 22) at term pregnancy, compared to women of those of normal body mass index
(n = 15). No alteration in expression of the other proteins investigated was noted.
Conclusions: The significant decrease in p160 ROCK-1 protein expression observed in the myometrium of obese
women at late gestation may contribute to an inhibitory effect on contractility at labour, due to its contribution to
calcium sensitisation and possibly other signalling pathways. These findings are relevant to the concept of
compromised myometrial function in obese parturients.
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Obesity is a big health problem in society, and is an
increasing one in obstetric practice [1]. A wide variety of
perinatal complications are associated with maternal
obesity including prolonged pregnancy, less likelihood of
spontaneous onset of labour at term, slower cervical
dilation, longer duration of labour and an increased
risk of intrapartum caesarean delivery [2,3]. Increased
maternal body mass index (BMI) has also been significantly
associated with ineffective uterine contractility [4], and the
reasons for this are complex, and have been linked to ele-
vated cholesterol levels (6) and a reduction in intracellular
free calcium [Ca(2+)] flux in previous reports [5]. These
findings suggest a possible dysregulation in myometrial
contractility pathways occurs in association with maternal* Correspondence: magsobrien99@hotmail.com
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reproduction in any medium, provided the orobesity, but there are minimal data to clearly support
this hypothesis or explain the potential mechanisms.
Adipocytokines have been postulated as having a metabolic
role which exerts an inhibitory effect on myometrium in
obese parturients. Our group has highlighted that leptin
along with other adipocytokines, apelin and ghrelin inhibit
uterine contractility in vitro [1,6-8]. However the potential
signalling pathways that are involved are unknown.
Uterine smooth muscle contraction is primarily regulated
by an increase in intracellular free calcium ([Ca2+]i), which
leads to the activation of calmodulin-dependent myosin
light chain kinase (MYLK). MYLK phosphorylates the regu-
latory myosin light chain (MLC), enhancing actin-myosin
ATPase activity to cause contraction [9]. Dephosphorylation
of the phosphorylated MLC by myosin phosphatase
(MYPT) results in relaxation [10]. Meanwhile, MYPT is
inhibited by phosphorylation by the protein kinase, Rho
(Ras homolog gene family, member) -associated, coiled-coilLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Patient Demographics of women with a BMI of








Mean +/− SEM 36.5 +/− 1.15 38.5 +/− 0.2 3.3 +/− 0.1 24.0 +/− 0.3
Range 29 - 45 37 - 41 2.6 – 4.2 21.7- 24.9
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or Thr853, either simultaneously or independently [11,12].
MYLK is activated by Ca2+-calmodulin whereas MYPT
is inhibited by phosphorylation by Ca2+-independent
mechanisms, leading to generation of increased MLC
phosphorylation and force for a given intracellular Ca2+
concentration, a phenomenon known as ‘calcium-sensi-
tisation’ [13]. Human pregnant myometrium expresses
Rho regulatory proteins [14], including ROCK-1 and 2
[15,16]. There seems to be no significant change in the
expression of ROCK-1 or 2 with pregnancy or labour
[15-17]. However, in leptin-receptor deficient mice there
is an altered contribution of RhoA/ROCK-1 signalling in
the contractile activity of myometrium, suggesting leptin
suppression of myometrial ROCK-1 and −2 expression
and function, resulting in an inability to generate tonic
contractions needed for delivery [18]. We therefore
hypothesised that the RhoA/ROCK pathway may be linked
to abnormal myometrial contractility in obese pregnant
women. The aim of this study was to determine the effect
of obesity in pregnancy on the expression of Rho and
ROCK associated proteins in myometrium at term gesta-
tion in obese pregnant women, and in a control group of
women with normal BMI.
Methods
Tissue samples
Biopsies were obtained at elective caesarean section in
the third trimester of pregnancy in the Department of
Obstetrics and Gynaecology, University College Hospital,
Galway, Ireland. Ethical committee approval for tissue col-
lection was obtained from the Research Ethics Committee
at University College Hospital Galway and recruitment
of patients was by informed written consent. The BMI
calculation for women recruited was based upon weight
and height measurements obtained at the first antenatal
visit. Normal BMI was classified as 18.5 to 24.9 kg/m2
and the obese category BMI was classified as 30 kg/m2 or
greater. The biopsy specimens were excised from the upper
portion of the lower segment of the uterus. Myometrial
samples were carefully dissected to minimise decidual
inclusion. Immediately upon collection, the tissue was
snap-frozen in liquid nitrogen in the operating theatre and
stored at −80°C.
Study patients
Biopsies were obtained at elective caesarean section (n = 37).
The reasons for elective caesarean section in the normal
BMI cohort (n = 15) included as follows: 1 previous
caesarean section (n = 4), 2 previous caesarean sections
(n = 5), breech presentation (n = 3), Intrauterine growth
restriction (IUGR) (n = 1), polyhydraminos (n = 1) and
previous endometrial ablation (n = 1). The reasons for
elective caesarean section in the obese category (n = 22)were as follows: 1 previous caesarean section (n = 8), 2
previous caesarean sections (n = 3), 3 previous caesarean
sections (n = 1), breech presentation (n = 5), previous
vaginal surgery (n = 1), congenital hearing impairment
(n = 1), foetal macrosomia (n = 1), previous myomectomy
(n = 1) and previous third degree perineal tear (n = 1) The
patient demographic data for both sets of samples is
presented in Tables 1 and 2.
Protein isolation
Human myometrial tissue was disrupted in liquid nitrogen
using a pestle and mortar prior to homogenisation in ice
cold lysis buffer [19] containing 10 mM HEPES pH 7.5, 10
mM MgCl2, 5 mM KCL, 0.1% Triton X-100, 0.1 mM
EDTA pH 8 (Sigma Aldrich, Dublin, Ireland) and a
complete mini-protease inhibitor tablet (Hoffmann-La
Roche Ltd., Basel, Switzerland) [20]. Cellular debris was
removed by centrifugation at 5,000 × RPM, at 4°C for 10
minutes. 5 X Laemmli buffer containing 50 mM DTT was
added to the supernatant, samples were used or stored
at −80°C.
Protein gel electrophoresis
The protein preparation was resolved by electrophoresis
on Mini-PROTEAN TGX precast 10% or 12% (Biorad,
Hercules, CA, USA) SDS (w/v) polyacrylamide gel elec-
trophoresis (SDS-PAGE) gels at 30–50 Volts (V) at room
temperature for 1–2 hours (BioRad, USA) in a buffer
containing 25 mol l-3 Tris base, pH 8.3, 19.2 mol l-2 glycine,
and 0.1% (w/v) SDS. The separated proteins were trans-
ferred to Immobilon-P transfer membranes (Millipore,
Billerica, MA, USA) at a constant voltage of 25 V at 4°C
overnight in transfer buffer containing 25 mol l-3 Tris
base, 192 mol l-3 glycine, and 20% methanol (v/v), high-
performance liquid chromatography (HPLC) grade (Sigma-
Aldrich, Dublin, Ireland). To ensure transfer and equal
loading of proteins, blots were stained with Ponceau S
solution (Sigma-Aldrich, Ireland) for 5 minutes, followed by
washing with de-ionised water. Membranes were blocked
upon incubation for 1 hour at room temperature with
phosphate-buffered saline (PBS; 1 mol l-2 phosphate buffer,
2.7 mol l-3 potassium chloride, and 1.37 mol l-1 sodium
chloride, pH 7.4) containing 0.05% Tween 20 (v/v)
(Sigma-Aldrich, Ireland) and 5% low-fat milk powder (w/v)
(Carnation Milk, Nestlé S.A., Vevey, Switzerland) to block
non-specific binding.
Table 2 Patient Demographics of women with a BMI









Mean +/− SEM 32.4 +/− 1.1* 39.0 +/− 0.1 3.6 +/− 0.1* 33.8 +/− 0.9***
Range 19 - 39 35 - 41 2.6 - 4.7 30.3 – 49.6
*** indicates a significance value of P < 0.001, * indicates a significance value

































Figure 1 A graph of the densitometric analysis of p160 ROCK-1
protein expression in human myometrium in women at term
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Blots were incubated overnight in 1 X PBS containing
0.05% Tween 20 and 5% milk with the primary antibody
at 4°C. The following primary antibodies (1/50 - 1/500
dilution) were utilised: anti-human ROCK-1 mouse poly-
clonal primary antibody (G-6 sc17794), ROCK-2 rabbit
polyclonal G6 (sc5561), RhoA mouse monoclonal (26C4
sc418), caveolin-1 rabbit polyclonal (N-20 sc894), Rho8
(Rnd3) mouse monoclonal (clone 4 sc53874), moesin goat
polyclonal (C-15 sc6410), pmoesin Thr558 goat polyclonal
(sc12895), OTR rabbit polyclonal (H-60 sc33209), RhoGDI
rabbit polyclonal (A20 sc360), MYPT 1 rabbit polyclonal
(H-130 sc25718), MYL-9 (MLC) (D-15 sc-34487), ppMLC
18/19 goat polyclonal (sc12896 Santa Cruz Biotechnology
Inc., Rockford, IL, USA), pMYPT 853 rabbit (Upstate,
Millipore, Billerica, MA, USA), pMYPT Thr696 rabbit
polyclonal (Upstate Millipore, USA ABS454), MLC mouse
monoclonal (ab97981 Abcam plc, Milton Road, Cambridge,
UK), RhoE (Rnd3) mouse monoclonal 3664 (Cell Signaling
Technology, Danvers, MA, USA), caspase 3 monoclonal
rabbit (Cell Signaling, USA 8G10 9665), cleaved caspase 3
rabbit monoclonal (Cell Signaling, USA Asp175 5A1E),
calponin mouse monoclonal (DakoCytomation Ltd, UK
M3556), pMAPK mouse monoclonal antibody to ERK1
and 2 pT185 and Y187 (Abcam, UK 50011) or 1/10,000
dilution of β-actin (ACTB) mouse monoclonal AC-15
(Sigma-Aldrich, Ireland) antibodies. Blots were washed
and incubated in either 1/1,000 dilution of donkey anti-
goat (Pierce Technology, Hallandale, FL., USA), 1/1000
goat anti-rabbit (Pierce Technology, USA), or 1/5000 dilu-
tion anti-mouse (Millipore, USA) horseradish peroxidase-
conjugated secondary antibodies, the bound secondary
antibody was detected as previously described. The mem-
branes were then scanned with the fluorescence imager
(FluorchemTM 8900, Alpha Innotech Corporation, San
Leandro, California, USA) and AlphaEaseFC software was
used to detect the signal, the image was processed and
protein expression levels were determined by densitometric
analysis compared to corresponding levels of the house-
keeping protein, β-Actin [8].pregnancy, with a normal BMI (n = 15), compared to those in
the obese cohort (n = 22). The graph represents β-Actin
normalised densitometric units of p160 ROCK-1 protein plotted
against BMI values ± SEM (indicated with error bars). *** indicates a
significance value of P < 0.001.Statistical analysis
Statistical 2-tailed unpaired student t-tests were performed
on the means of each group in order to assess thedifferences between groups, and graphs were constructed
using GraphPad Prism version 4 (GraphPad Software Inc.,
USA). The mean, significance (P) values, standard error
of the mean (SEM) and range values are presented in




The demographic details of all the patients in this study
(n = 37) are contained in Tables 1 and 2. We statistically
analysed the p160 ROCK-1 expression results in relation
to maternal age alone; the mean ± SEM for women of
less than 35 years (n = 14) was 0.71 ± 0.05, the mean for
women aged 35 years and over (n = 23) was 0.89 ± 0.07
(P = 0.08). Parity for those in the normal BMI group was
0: 6 women, 1: 8 women and ≥2: 1 woman and for those
in obese group, 0: 13 women, 1: 8 women and ≥2: 1
woman.
Western blots
The expression of p160 ROCK-1 protein was significantly
reduced in the myometrium from women in the obese
category (n = 22) compared to women from the normal
BMI group (n = 15) (Figure 1). The densitometric mean ±
SEM of the normal BMI group was 1.003 ± 0.0075 (range
0.72 - 1.66) compared to 0.4912 ± 0.033 for the obese
group (range 0.19 - 0.73), P < 0.001.
In a representative Western blot, the expression of p160
ROCK-1 was demonstrated to be significantly decreased
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(n = 7), compared to women from the normal BMI cohort
(n = 7) (P = 0.0007) (Figure 2). The expression of a lower
band in the ROCK-1 western blots was also observed to be
increased in the samples that demonstrated a significant
reduction in p160 ROCK-1 protein expression. In this
experiment the expression of the lower band was observed
to significantly increase in the same obese samples as
those above (P = 0.0064) (Figure 2).
The mean densitometric units for the expression of p160
ROCK-1 in the normal BMI group was 0.584 ± 0.044, the
range was 0.44 to 0.76. The mean densitometric value
for the p160 ROCK-1 protein in the high BMI group
was 0.34 ± 0.032 (range 0.22 - 0.49).
The mean value for the lower band in the p160







































































Figure 2 A representative western blot of p160 ROCK-1 protein expre
compared to those in the obese category (n = 7). The top band in the
unidentified band, indicated with the broken arrow, was also quantified. Th
weights (kDa) are represented by a line (a). Quantitative densitometric ana
presented below the western blots, with β-Actin-normalised densitometric
with error bars). The significance values (P) are indicated (b).(range 0.11 to 0.185). The mean expression value of the
lower band in the high BMI group was 0.269 ± 0.034
(range 0.16 - 0.39).
There were a series of proteins for which expression
was detected in samples but there was no alteration
thereof noted between the myometrium from the
women of normal BMI, and that obtained from women
in the obese category BMI. A list of these proteins is as
follows: RhoA, Rho kinase 2 (ROCK-2), Rho guanine
nucleotide dissociation inhibitor (RhoGDI), both phos-
phorylated and unphosphorylated myosin light chain
(MLC and ppMLC 18/19), phosphorylated and unphos-
phorylated myosin phosphatase (MYPT and pMYPT 696
and pMYPT 853), Rho family protein Rnd3, oxytocin
receptor (OTR), phosphorylated mitogen-activated pro-
tein kinase (pMAPK), caspase 3, phosphorylated moesin-Actin
ROCK-1










ssion in myometrium from women with normal BMI (n = 7)
first blot indicated with the arrow is p160 ROCK-1 while the lower
e corresponding β-Actin western blot is also presented. The molecular
lyses of the expression of the p160 ROCK-1 and the lower band are
units plotted against BMI values, at term pregnancy ± SEM (indicated
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http://www.rbej.com/content/11/1/79(pMoesin), caveolin-1 and calponin. This is demonstrated
in Figures 3 and 4.
Discussion
The findings from this study demonstrate a decrease in






















































































































Figure 3 Graphs of the densitometric analyses of the expression of R
in human myometrium from women with normal BMI (n = 15), comp
pmoesin and pMAPK (n = 7 for both groups).obese pregnant women at term. This is an interesting
finding considering the putative dysfunctional uterine ac-
tivity that is believed to occur in obese pregnant women
undergoing labour. The reasons for, or significance of, this
finding are unclear but it is tempting to speculate that
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Figure 4 Graphs of the densitometric analyses of the expression of RhoA/ROCK associated proteins, (p)(p)MYPT and (pp)MLC in
human myometrium from women with normal BMI (n = 15), compared to those in the obese category (n = 22), and calponin and
caveolin-1 (n = 7 for both groups).
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p160 ROCK-1 in calcium sensitisation, and also the roles
it plays in other signalling pathways linked to contractility
[10,12]. The strengths of this study are that the experiments
were carried out in a relatively large number of samples,
the clinical and BMI data are all reliable, the sampleswere collected and frozen freshly, there was no apparent
difference in relation to maternal age, and there was a
large difference in the expression levels observed. The
limitations of this study include the fact that protein
expression was investigated, but not protein activity, and
that all samples were obtained prior to the onset of labour.
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functional model. The potential signalling pathways that
may mediate the effects of such reduced expression are
many, and this would require an extensive series of
pharmacological experiments, which is a topic for further
study.
As a consequence of the finding of reduced expression
of p160 ROCK-1 in myometrium from pregnant women
at term, and the suggestion that this may compromise
the capacity of the myometrium to contract adequately,
we subsequently examined the expression of other
members of the RhoA/ROCK pathway. There was no
change in RhoA, ROCK-2, Rnd3, calponin, OTR or
caveolin-1 protein expression in association with increased
maternal BMI. Similarly no change was observed in
myometrial MYPT and MLC protein expression and
phosphorylation, or the phosphorylation of the ROCK
effector proteins moesin and MAPK. It is difficult to
propose an overall mechanism of effect linked to the
reduced p160 ROCK-1 expression observed, but the
concept remains that it may be clearly linked to reduced
myometrial contractility.
What could be responsible for the decrease in ROCK-1
expression? One possibility is that secretory factors
produced by adipose tissue of overweight and obese
women may alter the myometrial physiology. More than
100 substances including adipocytokines are secreted from
the adipose tissue [21]. Interestingly, there is an altered
contribution of RhoA/Rho kinase signalling in contractile
activity of myometrium in leptin receptor-deficient mice.
The authors of this latter study demonstrated that leptin
suppressed myometrial ROCK-1 and 2 expression and
function, resulting in an inability to generate tonic
contractions needed for delivery [18]. Thus, it is possible
that increased leptin levels in obese pregnant women
might be in part responsible for the reduction in ROCK-1
protein expression, and may result in reduced myometrial
contractility.
Another possibility in consideration of the results of
this study is that p160 ROCK-1 protein reduction
occurs, secondary to protein cleavage. The appearance
of the lower band in the ROCK-1 western blots
prompted us to investigate protease involvement in the
decline of the p160 ROCK-1 protein. Elevated caspase
3 levels have been noted in pregnant mouse, rat and
human uterus where it is thought to be involved in the
regulation of uterine quiescence [22-24]. We did detect
Caspase 3 protein in the myometrial biopsies however
there was no significant change in expression and no
observable cleaved caspase-3 protein. Indeed, phos-
phorylation of p160 ROCK-1 or other biochemical
mechanisms may be responsible for the additional
band. However, further investigation is necessary on
this matter.Conclusions
ROCK-1 plays a central role in myometrial contractility
and is closely linked to other signalling molecules in the
cell. The reduction in its expression demonstrated in
this study in the myometrium of obese pregnant women
at term may play a role in inhibiting contractility in
these women.
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